Oncology

Oncology covers companies developing therapies, diagnostics, and enabling technologies for cancer. On BioPharmSignal, this sector page groups businesses tied to solid tumors, hematologic malignancies, precision oncology, immuno-oncology, and other cancer-focused programs.

Why watch Oncology

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Oncology news

The latest feed items from companies currently grouped under Oncology.

1. 01
   2026-10-08 05:00 EST

   ARGXargenx Announces Positive Topline Results from Phase 2 Study of FB102 in Celiac Disease

   Source: Argenx

2. 02
   2026-10-08 05:00 EST

   ARGXargenx Provides Update on Phase 3 UNITY Study of Efgartigimod SC in Sjögren's Disease

   Source: Argenx

3. 03
   2026-10-07 13:14 EST

   AIMAIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays

   Source: AIM ImmunoTech

4. 04
   2026-10-07 12:48 EST

   ARTLArtelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform

   Source: Artelo Biosciences

5. 05
   2026-10-07 12:45 EST

   MBRXMoleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit

   Source: Moleculin Biotech, Inc.

6. 06
   2026-10-07 12:30 EST

   RNXTRenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial

   Source: RenovoRx

7. 07
   2026-10-07 12:15 EST

   MKTMAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer

   Source: Maia Biotechnology

8. 08
   2026-10-07 12:00 EST

   KYTXKyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026

   Source: Kyverna Therapeutics

9. 09
   2026-10-07 11:15 EST

   KURACaspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

   Source: Kura Oncology

10. 10
    2026-10-07 10:16 EST

    CATXPerspective Therapeutics Announces Acceptance of [212Pb]VMT-α-NET Data for Presentation at the NANETS 2026 Multidisciplinary NET Medical Symposium

    Source: Perspective Therapeutics

11. 11
    2026-10-07 05:00 EST

    NRIXNurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia

    Source: Nurix Therapeutics

12. 12
    2026-10-06 20:30 EST

    MMSIMerit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026

    Source: Merit Medical

13. 13
    2026-10-06 20:05 EST

    CRBUCaribou Biosciences to Evaluate Strategic Alternatives

    Source: Caribou

14. 14
    2026-10-06 20:05 EST

    ELVNEnliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic Myeloid Leukemia

    Source: Enliven Therapeutics

15. 15
    2026-10-06 20:00 EST

    INABIN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    Source: IN8bio

16. 16
    2026-10-06 14:00 EST

    GSKViiV Healthcare’s long-acting HIV treatment Cabenuva (cabotegravir + rilpivirine) meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia

    Source: GSK plc

17. 17
    2026-10-06 13:19 EST

    BIAFbioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026

    Source: bioAffinity Technologies, Inc.

18. 18
    2026-10-06 12:30 EST

    LIXTNOMAD POWER SOLUTIONS LAUNCHES NATIONWIDE MOBILE POWER DEMONSTRATION TOUR

    Source: Lixte Biotechnology Holdings

19. 19
    2026-10-06 12:25 EST

    ICCMIceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site

    Source: IceCure Medical

20. 20
    2026-10-06 12:00 EST

    PDSBPDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases

    Source: PDS Biotechnology Corporation

Companies in Oncology

277 companies tagged with Oncology.

Frequently Asked Questions